EADV 2026: Real-World Outcomes with Sonidegib and Cemiplimab in Advanced Cutaneous Carcinomas

How do sonidegib and cemiplimab perform in real-world clinical practice? Dr. Chiara Del Re, dermatologist at Magna Graecia University in Italy, shares findings from a single-center observational study, exploring efficacy, lesion reduction, and safety in patients with advanced cutaneous carcinomas presented at EADV 2026.